Pittsburgh Compound B offers early proof of Alzheimer’s

April 23, 2008 Pittsburgh Compound B offers early proof of Alzheimer’s Yomi Wrong -------------------------------------------------------------------------------- Though University of Pittsburgh Alzheimer's disease researchers believed it all along, groundbreaking research now confirms that Pittsburgh Compound B binds to the beta-amyloid deposits found in the brains of patients with Alzheimer's. The finding is a major step toward an early, definitive diagnosis of the memory-stealing disease in living patients. "As excited as researchers get, we are pretty excited," said senior author Dr. Steven T. DeKosky, a professor of neurology, psychiatry, neurobiology, and human genetics and director of the Alzheimer's Disease Research Center at the University of Pittsburgh.

See full article and related articles at DiagnosticImaging.com
This article was republished with permission from CMPMedica, LLC